| GC32669-1mg |
|
136079-82-8 |
Arrhythmic-Targeting Compound 1
|
0 |
C25H29N3O4S |
|
|
|
| GC32668-20mg |
|
335619-12-0 |
Arrhythmias-Targeting Compound 1
|
0 |
C22H32N4O2 |
|
|
|
| GC32668-10mg |
|
335619-12-0 |
Arrhythmias-Targeting Compound 1
|
0 |
C22H32N4O2 |
|
|
|
| GC32668-5mg |
|
335619-12-0 |
Arrhythmias-Targeting Compound 1
|
0 |
C22H32N4O2 |
|
|
|
| GC32668-1mg |
|
335619-12-0 |
Arrhythmias-Targeting Compound 1
|
0 |
C22H32N4O2 |
|
|
|
| GC32667-20mg |
|
96487-37-5 |
|
0 |
C19H20N4O2 |
|
|
|
| GC32667-10mg |
|
96487-37-5 |
|
0 |
C19H20N4O2 |
|
|
|
| GC32667-5mg |
|
96487-37-5 |
|
0 |
C19H20N4O2 |
|
|
|
| GC32667-1mg |
|
96487-37-5 |
|
0 |
C19H20N4O2 |
|
|
|
| GC32666-20mg |
|
35035-05-3 |
Timepidium bromide (Sesden)
|
0 |
C17H22BrNOS2 |
|
|
|
| GC32666-10mg |
|
35035-05-3 |
Timepidium bromide (Sesden)
|
0 |
C17H22BrNOS2 |
|
|
|
| GC32666-5mg |
|
35035-05-3 |
Timepidium bromide (Sesden)
|
0 |
C17H22BrNOS2 |
|
|
|
| GC32666-1mg |
|
35035-05-3 |
Timepidium bromide (Sesden)
|
0 |
C17H22BrNOS2 |
|
|
|
| GC32665-10mg |
|
65023-16-7 |
|
0 |
C25H33ClN2O7 |
|
|
|
| GC32665-5mg |
|
65023-16-7 |
|
0 |
C25H33ClN2O7 |
|
|
|
| GC32665-1mg |
|
65023-16-7 |
|
0 |
C25H33ClN2O7 |
|
|
|
| GC32664-20mg |
|
204643-75-4 |
|
0 |
C26H28N4O2 |
|
|
|
| GC32664-10mg |
|
204643-75-4 |
|
0 |
C26H28N4O2 |
|
|
|
| GC32664-5mg |
|
204643-75-4 |
|
0 |
C26H28N4O2 |
|
|
|
| GC32664-1mg |
|
204643-75-4 |
|
0 |
C26H28N4O2 |
|
|
|
